KALV - KalVista Pharma Qarzning balans kapitallashuviga nisbati
KalVista Pharmaceuticals (KALV) uchun ushbu narxlar grafigi yuqori marjalarni ta'minlovchi keng omborlar tarmog'i orqali kamyob dori vositalarini taqsimlash samaradorligini ko'rsatadi. Shu bilan birga, KalVista Pharmaceuticals (KALV) rivojlanish bosqichida qolmoqda, foyda keltirmayapti va 0.00 miqdorida qayd etilgan tadqiqot va ishlanmalarga (R&D) mablag' sarflamoqda. Shuningdek, biznes shishlar uchun davolash usullarini kashf qilish maqsadida sintez avtomatlashtirishni tibbiy ekspertiza bilan birlashtirgan holda AI texnologiyasini joriy qilmoqda.
%20Qarzning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_KALV_-_KalVista-Pharmaceuticals_-_Debt-to-Net-Assets-Ratio "KalVista Pharmaceuticals - KALV Qarzning balans kapitallashuviga nisbati (davr: 04.07.2022 - 21.06.2026) | 👁️GURU.Markets👁️")
KalVista Pharma (KALV) kompaniyasi koʻrsatkichlari kesimi va tahlili
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati KalVista Pharmaceuticals|KALV - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati KalVista Pharmaceuticals Inc|KALV - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans kapitallashuviga nisbati KalVista Corp|KALV - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi KalVista Pharmaceuticals
Kompaniyaning jamlanma tahliliyoti:KalVista Pharmaceuticals (KALV)
Ushbu ko'rsatkich umumiy qarz majburiyatlarining kitob kapitalizatsiyasiga nisbatini belgilaydi, bu esa investorlarga bozor shovqinlarisiz biznesning tashqi zarbalarga moliyaviy barqarorligini baholash imkonini beradi. Qarzning kitob kapitalizatsiyasiga nisbati tendentsiyasini tahlil qilish orqali KalVista Pharmaceuticals (KALV) irsiy angioedema davolash uchun innovatsion oral dori vositalarini ishlab chiqish bilan leveraj kapitalini qanchalik samarali muvozanatga keltirayotganini tushunish mumkin.
KalVista Pharmaceuticals kimlar bilan raqobatlashadi
Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. PHAR|Qarzning balans qiymatiga nisbati nektar.com (NKTR)|UPB: Balans kapitallashuviga qarzlar|Zenas Bio - Balans qiymatiga qarzlar|Immunome Corp - Qarzning balans kapitallashuviga nisbati|GOSS - Balans kapitallashuviga qarzlar|SEPN: Balans kapitallashuviga qarzlar|PVLA (pieris.com) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Savara|Qarzning balans kapitallashuviga nisbati Rigel Pharma (RIGL)|Qarzning balans qiymatiga nisbati AnaptysBio Corp (ANAB)|Qarzning balans kapitallashuviga nisbati Astria Corp (ATXS)|Balans kapitallashuviga qarzlar ENGN|RAPT Therapeutics Inc. - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati JBIO (Aerovate)|Aclaris Therapeutics Inc. (ACRS) - Sof aktivlarga qarzlar|KYTX - Qarzning balans qiymatiga nisbati|Tiziana Life Sciences, Ltd. (TLSA) - Qarzning balans kapitaliga nisbati|CABA (Cabaletta Bio, Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar ventyxbio.com (VTYX)|Theratechnologies (THTX) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati AVTX (Avalo Therapeutics, Inc.)|Eledon (ELDN) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Agenus, Inc AGEN|Balans kapitallashuviga qarzlar Climb Bio Inc (CLYM)|ZURA - Qarzning sof aktivlarga nisbati|ATYR: Balans kapitallashuviga qarzlar|ADAG (Adagene Inc.) - Balans kapitallashuviga qarzlar|IMA - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati STTK|Qarzning balans kapitallashuviga nisbati EQ (Equillium, Inc.)|Qarzning balans qiymatiga nisbati connectbiopharm.com (CNTB)|Balans kapitallashuviga qarzlar IMUX (Immunic)|Balans kapitallashuviga qarzlar Atara Biotherapeutics, Inc. ATRA|IFRX: Balans kapitallashuviga qarzlar|XFOR - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ACET|Balans qiymatiga qarzlar Celularity|INMB (INmune Bio) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Barinthus Biotherapeutics PLC (BRNS)|Qarzning balans qiymatiga nisbati Kezar Life Sciences, Inc|Qarzning balans kapitaliga nisbati SAB Biotherapeutics Inc (SABS)|Balans kapitallashuviga qarzlar AKTX|Sof aktivlarga qarzlar Enlivex Therapeutics Ltd ENLV|QTTB: Balans kapitallashuviga qarzlar|GOVX - Qarzning balans qiymatiga nisbati|EDSA: Balans kapitallashuviga qarzlar|IBIO (iBio Corporation) - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Carisma Therapeutics Inc|Qarzning balans kapitallashuviga nisbati XTLB|BOLT (Bolt Biotherapeutics) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar HCWB (hcwbiologics.com)|Qarzning balans kapitallashuviga nisbati APVO (Aptevo Therapeutics Inc.)|Balans kapitallashuviga qarzlar AIM ImmunoTech, Inc. AIM|Aditxt Corp - Balans kapitallashuviga qarzlar|GRI: Balans kapitallashuviga qarzlar|XORTX Therapeutics (XRTX) - Qarzning balans kapitallashuviga nisbati|Qarzning balans kapitallashuviga nisbati Vyome Holdings Inc.|Qarzning balans qiymatiga nisbati Revelation Bio|Qarzning balans kapitallashuviga nisbati INDP|SCNI - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati calcimedica.com (CALI)|Balans kapitallashuviga qarzlar Affimed N.V.|Qarzning sof aktivlarga nisbati Allakos Inc ALLK|HOOKIPA - Balans kapitallashuviga qarzlar|IGMS: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati iTeos Therapeutics ITOS|OCEA (oceanbiomedical.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati TCBP|Qarzning balans qiymatiga nisbati Third Harmonic Bio Inc.